Psoriatic arthritis is a chronic inflammatory joint condition that often develops in individuals with psoriasis. Symptoms of PsA include joint pain, stiffness, and swelling, along with skin patches characteristic of psoriasis.
Studies suggest that it affects around 30% of people with psoriasis, with symptoms ranging from mild to severe and potentially leading to joint damage and disability if left untreated.
In response to this pressing medical need, Hightower is actively conducting clinical trials to evaluate the safety and efficacy of an investigational drug. This research aims to provide novel therapeutic options to alleviate symptoms and improve the quality of life for those living it.
*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.*
